Fucosterol

CAS No. 17605-67-3

Fucosterol( —— )

Catalog No. M21489 CAS No. 17605-67-3

Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 78 In Stock
10MG 133 In Stock
25MG 228 In Stock
50MG 339 In Stock
100MG 482 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fucosterol
  • Note
    Research use only, not for human use.
  • Brief Description
    Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.
  • Description
    Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARα
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17605-67-3
  • Formula Weight
    412.7
  • Molecular Formula
    C29H48O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol:16.67 mg/mL (4.39 mM)
  • SMILES
    CC(C)/C(/CC[C@@H](C)[C@@H](CC1)[C@@](C)(CC2)[C@@H]1[C@H]1[C@H]2[C@@](C)(CC[C@@H](C2)O)C2=CC1)=C/C
  • Chemical Name
    Stigmasta-524(28)-dien-3-ol (3beta24E)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jung HA et al. Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3T3-L1 adipocytes. Arch Pharm Res. 2014 Jun;37(6):713-20.
molnova catalog
related products
  • Pioglitazone hydroch...

    Pioglitazone hydrochloride can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue.

  • LY518674

    LY518674 decreases triglycerides and increases HDL-C and is used for the treatment of atherosclerosis.

  • GW 501516

    A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay.